Clinical-stage endocrine pharma advancing novel therapeutics for metabolic and neuroendocrine disease
Crinetics is a public biotech company developing therapeutics for endocrine disorders and related tumors. The tech stack is heavily Microsoft + cloud (Azure, Synapse, Data Lake) with critical pharmaceutical infrastructure (Veeva Vault eTMF, Veeva, ServiceNow, Workday), reflecting a company navigating complex regulatory and operational scale. Recent hiring acceleration across healthcare, research, and ops roles—alongside active projects in IND-enabling decisions, dose selection, and 2253 submission support—signals active advancement through early clinical development phases.
Notable leadership hires: Medical Director
Crinetics is a San Diego-based biopharmaceutical company founded in 2008 and operating as a public company with 501–1,000 employees. The company focuses on discovering, developing, and commercializing novel therapeutics targeting endocrine diseases and endocrine-related tumors. The business spans clinical development (multiple concurrent programs), manufacturing operations, regulatory affairs (including 2253 submissions and IND strategies), and commercial functions. Infrastructure pain points center on data governance across R&D, privacy regulation compliance, and managing a complex cloud environment—typical of biotech scaling from discovery through clinical and manufacturing phases.
Active projects include clinical development strategy, integrated evidence generation, IND-enabling decisions, first-in-human dose selection, lead optimization campaigns, and 2253 submission support—indicating progression through early-to-mid clinical development for multiple endocrine-focused programs.
Core infrastructure: Azure, Synapse Analytics, Data Lake, Data Factory. Pharma-specific: Veeva Vault eTMF, Veeva, ServiceNow. Operations: Workday, Azure DevOps, GitHub. Adopting: Veeva (expanded implementation).
Other companies in the same industry, closest in size